Corbus Pharmaceuticals Holdings, Inc. (CRBP)Healthcare | Biotechnology | Norwood, United States | NasdaqCM
10.59 USD
+0.45
(4.438%)
⇧
(April 17, 2026, 4 p.m.
EDT)
After hours: 10.80 +0.21 (1.983%) ⇧ (April 17, 2026, 7:27 p.m. EDT) Short-term: ★★★☆☆ | Long-term: ★★★☆☆ | Dividends: ★☆☆☆☆ |
Hot Take | April 18, 2026, 10:55 p.m. EDT
Despite negative fundamentals and record-preparatory insider selling, the speculative sentiment is overwhelmingly bullish: speculators are positioning aggressive call specs at $12.50, signaling a belief in a near-term 20%+ upside move over the next month driven by upcoming clinical data and favorable FDA alignment. |
| Model | MAE |
|---|---|
| AutoETS ✓ | 0.087936 |
| MSTL | 0.089350 |
| AutoTheta | 0.297290 |
| AutoARIMA | 0.370556 |
Forecast horizon: 45 days | Selected: AutoETS
| Forecast Reliability | |
|---|---|
| Score | 63% |
| H-stat | 1.72 |
| Ljung-Box p | 0.000 |
| Jarque-Bera p | 0.239 |
| Excess Kurtosis | -1.20 |
| Attribute | Value |
|---|---|
| Sector | Healthcare |
| Debt to Equity Ratio | 1.107 |
| Market Cap | 187,829,152 |
| Forward P/E | -2.17 |
| Beta | 2.79 |
| Website | https://www.corbuspharma.com |
As of April 18, 2026, 10:55 p.m. EDT: Call options dominate put activity significantly across all expirations (May, June, Sept), with heavy Open Interest clustering at the $12.50 strike (a +18% distribution spike vs -5.6% for ATM) and $7.50 strike, indicating strong bullish positioning. Put activity is extremely low, concentrated only deep out-of-the-money ($2.50 strike) suggesting minimal hedging against downside, while long calls at expirations 4-7 months ahead show net positive positioning relative to strikes.
| Attribute | Value |
|---|---|
| 52 Week Change | 0.6809524 |
| Address1 | 500 River Ridge Drive |
| All Time High | 323.4 |
| All Time Low | 2.11 |
| Ask | 12.13 |
| Ask Size | 1 |
| Average Analyst Rating | 1.2 - Strong Buy |
| Average Daily Volume10 Day | 249,940 |
| Average Daily Volume3 Month | 200,169 |
| Average Volume | 200,169 |
| Average Volume10Days | 249,940 |
| Beta | 2.789 |
| Bid | 9.09 |
| Bid Size | 1 |
| Book Value | 8.375 |
| City | Norwood |
| Compensation As Of Epoch Date | 1,767,139,200 |
| Country | United States |
| Crypto Tradeable | 0 |
| Currency | USD |
| Current Price | 10.59 |
| Current Ratio | 8.069 |
| Custom Price Alert Confidence | HIGH |
| Date Short Interest | 1,774,915,200 |
| Day High | 10.99 |
| Day Low | 10.15 |
| Debt To Equity | 1.107 |
| Display Name | Corbus Pharmaceuticals |
| Earnings Timestamp | 1,773,059,400 |
| Earnings Timestamp End | 1,777,984,200 |
| Earnings Timestamp Start | 1,777,984,200 |
| Ebitda | -85,077,000 |
| Ebitda Margins | 0.0 |
| Enterprise To Ebitda | -0.308 |
| Enterprise Value | 26,193,154 |
| Eps Current Year | -4.66444 |
| Eps Forward | -4.8825 |
| Eps Trailing Twelve Months | -5.9 |
| Esg Populated | 0 |
| Exchange | NCM |
| Exchange Data Delayed By | 0 |
| Exchange Timezone Name | America/New_York |
| Exchange Timezone Short Name | EDT |
| Fifty Day Average | 8.825 |
| Fifty Day Average Change | 1.7650003 |
| Fifty Day Average Change Percent | 0.20000005 |
| Fifty Two Week Change Percent | 68.095245 |
| Fifty Two Week High | 20.56 |
| Fifty Two Week High Change | -9.969999 |
| Fifty Two Week High Change Percent | -0.48492217 |
| Fifty Two Week Low | 5.9 |
| Fifty Two Week Low Change | 4.69 |
| Fifty Two Week Low Change Percent | 0.79491526 |
| Fifty Two Week Range | 5.9 - 20.56 |
| Financial Currency | USD |
| First Trade Date Milliseconds | 1,414,416,600,000 |
| Float Shares | 12,741,521 |
| Forward Eps | -4.8825 |
| Forward P E | -2.1689708 |
| Free Cashflow | -37,728,752 |
| Full Exchange Name | NasdaqCM |
| Full Time Employees | 36 |
| Gmt Off Set Milliseconds | -14,400,000 |
| Gross Margins | 0.0 |
| Gross Profits | -70,095,000 |
| Has Pre Post Market Data | 1 |
| Held Percent Insiders | 0.0059399996 |
| Held Percent Institutions | 0.75916 |
| Implied Shares Outstanding | 17,736,465 |
| Industry | Biotechnology |
| Industry Disp | Biotechnology |
| Industry Key | biotechnology |
| Is Earnings Date Estimate | 1 |
| Language | en-US |
| Last Fiscal Year End | 1,767,139,200 |
| Last Split Date | 1,676,332,800 |
| Last Split Factor | 1:30 |
| Long Business Summary | Corbus Pharmaceuticals Holdings, Inc., a clinical stage company, develops and commercializes therapeutics for cancer and obesity. Its pipeline includes CRB-701, an antibody drug conjugate that targets the expression of Nectin-4 on cancer cells to release a cytotoxic payload of monomethyl auristatin E; and CRB-913, a peripherally restricted cannabinoid type-1 receptor inverse agonist for the treatment of obesity. The company was incorporated in 2009 and is headquartered in Norwood, Massachusetts. |
| Long Name | Corbus Pharmaceuticals Holdings, Inc. |
| Market | us_market |
| Market Cap | 187,829,152 |
| Market State | CLOSED |
| Max Age | 86,400 |
| Message Board Id | finmb_254045988 |
| Most Recent Quarter | 1,767,139,200 |
| Net Income To Common | -78,537,000 |
| Next Fiscal Year End | 1,798,675,200 |
| Non Diluted Market Cap | 187,651,789 |
| Number Of Analyst Opinions | 9 |
| Open | 10.25 |
| Operating Cashflow | -64,491,000 |
| Operating Margins | 0.0 |
| Payout Ratio | 0.0 |
| Phone | 617 963 0100 |
| Post Market Change | 0.21000004 |
| Post Market Change Percent | 1.9830031 |
| Post Market Price | 10.8 |
| Post Market Time | 1,776,468,461 |
| Previous Close | 10.14 |
| Price Eps Current Year | -2.270369 |
| Price Hint | 2 |
| Price To Book | 1.2644776 |
| Profit Margins | 0.0 |
| Quick Ratio | 7.963 |
| Quote Source Name | Nasdaq Real Time Price |
| Quote Type | EQUITY |
| Recommendation Key | strong_buy |
| Recommendation Mean | 1.2 |
| Region | US |
| Regular Market Change | 0.45 |
| Regular Market Change Percent | 4.43787 |
| Regular Market Day High | 10.99 |
| Regular Market Day Low | 10.15 |
| Regular Market Day Range | 10.15 - 10.99 |
| Regular Market Open | 10.25 |
| Regular Market Previous Close | 10.14 |
| Regular Market Price | 10.59 |
| Regular Market Time | 1,776,456,000 |
| Regular Market Volume | 546,318 |
| Return On Assets | -0.32904997 |
| Return On Equity | -0.54175997 |
| Sand P52 Week Change | 0.38150132 |
| Sector | Healthcare |
| Sector Disp | Healthcare |
| Sector Key | healthcare |
| Shares Outstanding | 17,736,464 |
| Shares Percent Shares Out | 0.0683 |
| Shares Short | 1,211,398 |
| Shares Short Previous Month Date | 1,772,150,400 |
| Shares Short Prior Month | 1,316,296 |
| Short Name | Corbus Pharmaceuticals Holdings |
| Short Percent Of Float | 0.0792 |
| Short Ratio | 5.36 |
| Source Interval | 15 |
| State | MA |
| Symbol | CRBP |
| Target High Price | 57.0 |
| Target Low Price | 28.0 |
| Target Mean Price | 40.55556 |
| Target Median Price | 38.0 |
| Total Cash | 163,268,992 |
| Total Cash Per Share | 9.205 |
| Total Debt | 1,633,000 |
| Tradeable | 0 |
| Trailing Annual Dividend Rate | 0.0 |
| Trailing Annual Dividend Yield | 0.0 |
| Trailing Eps | -5.9 |
| Trailing Peg Ratio | None |
| Triggerable | 1 |
| Two Hundred Day Average | 10.1294 |
| Two Hundred Day Average Change | 0.4605999 |
| Two Hundred Day Average Change Percent | 0.045471586 |
| Type Disp | Equity |
| Volume | 546,318 |
| Website | https://www.corbuspharma.com |
| Zip | 2,062 |